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Abstract
Background: The generic and oral health-related quality of life (QoL) has provided opportunity for investigation of
the interrelations among generic health, oral health, and related outcomes. The purpose of this study was to
identify the generic and oral QoL in the patients with oral mucosal disease (OMD).
Methods: Five hundred and thirty-eight OMDs were recruited in this study. The instruments applied were Chinese
version of the 36-item short form health survey (SF-36) and the short-form of Oral Health Impact Profile (OHIP-14).
Results: The mean score of sum OHIP-14 was significantly higher in the patients with OMD (10.81 ± 9.01)
compared with those in the healthy subjects (HS) (6.55 ± 6.73) (p < 0.001, Mann-Whitney U test). 56.51% of the
OMD patients and 12.94% of the HS reported at least one oral negative impact (p < 0.001, Chi-square test). The
overall mean score of SF-36 was significantly lower in the patients with OMD (74.54 ± 12.77) compared with those
in the HS (77.97 ± 12.39) (p = 0.021, t-test).
Conclusions: Administration of specific and generic questionnaires of QoL can provide us a detailed picture of the
impact of OMDs on patients, and both generic and oral QoL were impaired in the patients with OMD.
Background
Oral mucosal diseases (OMDs) are common, and many
of them are unknown cause. For example, recurrent
aphthous stomatitis (RAS) affects about 0.5-60% of the
population [1,2]. There is no medication gives comple-
tely reliable relief. Patients with OMD such as pemphi-
gus, which is a rare but serious and highly disabling
immunobullous disease of the skin and mucous mem-
branes, can be suffered from life-threatening symptom
and be influenced daily life in many ways. Hence, the
consequences of OMDs are not only physical, they are
also social and psychological. These diseases seriously
impair quality of life (QoL) in a large number of indivi-
duals and can affect various aspects of life, including
oral function, appearance, and interpersonal relation-
ships [3-5]. Information regarding the impact of OMD
on QoL is a recognized need. The importance of embra-
cing patients’ views in assessing oral health needs and in
treatment planning has been advocated. Therefore a
number of different patient centered oral health status
measures have been developed over the past decade to
assess the physical, social and psychological conse-
quences of oral health and the impact of oral health sta-
tus on QoL. These measures are thought to
complement traditional clinical oral health status mea-
sures, to improve communication between patients and
clinical physicians, and provide greater understanding of
the consequences of oral disease upon day to day living
and life quality [6,7].
The 36-item short form health survey (SF-36) is
designed as a generic indicator of health status with a
wide range of types and severity of conditions [8]. The
oral health impact profile (OHIP) is an instrument
designed to measure oral-health-related QoL. The short-
form of OHIP (OHIP-14) is reported to be a useful
instrument for use in a clinical setting with good relia-
bility, validity and precision [9].
In the recent study, active oral ulcers were observed to
be a significant factor for poor oral health [10]. López-
Jornet et al. addressed patients with burning mouth syn-
drome (BMS) yield poorer scores on all scales of SF-36
and OHIP-49 [11]. The purpose of this study was to
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OMD using SF-36 questionaire and OHIP-14.
Methods
Subjects
This was an observational study to evaluate the self-per-
ceived health-related QoL in the patients with OMD.
Five hundred and twenty four first-visting patients diag-
nosed as various OMDs at the Department of Oral
Mucosal Diseases, Shanghai Ninth People’sH o s p i t a l ,
Shanghai Jiao Tong University School of Medicine dur-
ing August of 2009 to April of 2010, were enrolled.
Among 524 patients, 14 patients were involved in 2 dis-
orders. Overall, 538 cases of OMD included RAS, oral
lichen planus (OLP), burning mouth syndrome (BMS),
paraesthesia, candidosis, cheilitis, oral leukoplakia, dis-
coid lupus erythematosus, atrophic glossitis, stomatitis,
herpes zoster, geographic tongue, hyperkeratosis, herpes
simplex, pemphigus, dry mouth and the other OMDs.
We categorized these OMDs into 5 groups: RAS, OLP,
BMS & paraesthesia, candidosis, and others, which
including the various types of OMDs whose number
less than 30. The healthy subjects (HS) were 85 healthy
volunteers over 14 years of age. Among them, 29 were
recruited from a local community after oral screening
by a dentist (L-J. L), and the other 56 were recruited
from the family members of patients with OMD studied.
The study was approved by the ethics committee of
Shanghai Ninth People’s Hospital (#200703). The
enrolled subjects were given detailed information about
the study. The interview was carried out after receiving
informed consent from the subjects. The information
collected included age, sex, city of origin, and clinical
diagnosis. Subjects were given self-administered ques-
tionnaires of Chinese version SF-36 and OHIP-14
[12,13].
Inclusion and exclusion criteria
Inclusion criteria for patients with OMD in the study
were: first-visting outpatients at the Department of Oral
Mucosal Diseases during the study period, aged over 14
years, and diagnosed as OMD in accordance with clini-
cal findings and/or biopsy. Exclusion criteria for patients
with OMD were: 14 or under 14 years or consecutive
OMD patients. Inclusion criteria for HS were: After oral
screening, volunteers aged over 14 years without OMD,
were included. Exclusion criteria for HS were: 14 or
under 14 years or OMD patients.
Questionnaires
The standard version of the Health Questionnaire SF-36
contained 8 areas. Physical functioning, Role limitations
physical, Bodily pain, General medical health, Vitality,
Social functioning, Role limitations emotional and Mental
health. It evaluated the QoL of the people of which 14
years of age and older during the 4 weeks prior to the
interview. The higher scores indicated better health; thus,
0 was the worst state of health and 100 the ideal state of
health. The Chinese vesion of SF-36 questionnaire used in
this study was translated and validated by Li et al [12].
The OHIP-14 contained 7 different domains: Functional
limitation items, Physical pain items, Psychological dis-
comfort items, Physical disability items, Psychological dis-
ability items, Social disability items and Handicap items.
We used Chinese version developed by Xin et al [13]. The
OHIP-14 scores were calculated in two ways [14]. The
first method was to sum the numeric response codes for
all 14 items (sum OHIP-14). For each of the 14 OHIP
questions, subjects were asked how frequently they had
experienced impact in the preceding 12 months using a 5-
point scale coded 4 = very often, 3 = fairly often, 2 = occa-
sionally, 1 = hardly ever and 0 = never. The higher scores
indicated the worse oral health. This method was irrespec-
tive of their frequency and incorporated the full range of
impact responses. The second method was a simple
counting (OHIP-14 sc) of the number of items to which a
subject responded ‘fairly often’ or ‘very often’.T h i s
reduced the response scale to a dichotomy and indicated
the frequency of the occurrence of negative impact on a
yearly level.
Statistical analysis
Data was analyzed using the SAS 8.2 statistics program.
A descriptive study was made of each variable. Mann-
Whitney U test was used to compare the sum OHIP-14
in each group. Independent t-test was used in compari-
sons of the scores of the groups in SF-36 and age. Chi-
square test was used to compare the constituent ratio
about fairly often and very often of people reporting
social impact items and gender in each group. Probabil-
ity for p ≤ 0.05 was accepted as significant.
Results
Baseline characteristics of patients with OMD and HS
Among the various OMDs (Table 1), patients with RAS
contained 76 males (46.63%) with a mean age of 48.5
(SD = 16.2), patients with OLP contained 33 males
(27.27%) with a mean age of 49.3 (SD = 16.2), patients
with BMS & paraesthesia contained 10 males (23.26%)
with a mean age of 51.9 (SD = 15.7), patients with can-
didosis contained 15 males (40.54%) with a mean age of
50.0 (SD = 17.1), patients with others OMD contained
78 males (44.83%) with a mean age of 47.1 (SD = 17.6)
and HS contained 31 males (36.47%) with a mean age of
46.3 (SD = 16.7). No significance of age and gender was
found among each group.
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the patients with OMD
OHIP scores were calculated using the summary and
simple-count scores method. The distribution of sum
OHIP-14 ranged from 0 to 53 was highly skewed; how-
ever, the total mean score of sum OHIP-14 was signifi-
cantly worse in the patients with OMD (10.81 ± 9.01)
compared with those in the HS (6.55 ± 6.73, p < 0.001,
Mann-Whitney U test). Age (p = 0.247, t-test) and gen-
der (p = 0.606, Chi-square test) did not affect the sum
OHIP-14 scores. It indicated that OHIP-14 could discri-
minate between OMD and HS groups. The mean scores
of 2 different domains of OHIP-14, which including
Physical pain and Psychological discomfort were signifi-
cantly worse in the patients with OMD than those in
t h eH S( T a b l e2 ) .T h eo t h e r5d o m a i n so fO H I P - 1 4 ,
which including Functional limitation, Physical disability,
Social disability, Psychological disability and Handicap,
showed no difference between OMD and HS. In addi-
tion, the Painful aching and Uncomfortable to eat were
the two most highly scored items of OHIP-14 in the
patients with OMD.
Next, we compared the total mean score of sum
O H I P - 1 4i ne a c hg r o u po fO M D sw i t hH S .T h em e a n
score of sum OHIP-14 was significantly worse in the
patients with RAS (16.14 ± 10.05, p < 0.001, Mann-
Whitney U test), OLP (8.89 ± 8.02, p = 0.008, Mann-
Whitney U test), BMS & paraesthesia (8.88 ± 7.07, p =
0.033, Mann-Whitney U test) and others (8.13 ± 7.19, p
= 0.05, Mann-Whitney U test) compared with that in
HS (6.55 ± 6.73). But no significant difference was
found between the ‘Candidosis’ group and HS.
Furthermore, to evaluate the frequency of the occur-
rence of negative impact in the patients with OMD, we
catogorized the subjects with responses ‘very often’ and
‘fairly often’ in OHIP-14 statement as a negative impact
group and analyzed the number of negative impacts.
56.51% of the OMD patients and 12.94% of HS reported
at least one oral negative impact over the last year. For
all 7 domains of OHIP-14, the OMD patients with sig-
nificant higher numbers reporting ‘very often’ and ‘fairly
often’ in comparison with HS (Table 3). There was no
negative impact reporting of Diet unsatisfactory, Inter-
rupt meals, Difficulty doing jobs, and Life less satisfying
in HS. The lower percentage of negative impact report-
ing in OMD was the sub-iterm of Embarrassed (2.97%),
Difficulty doing jobs (2.60%) and Unable to function
(2.04%) (Table 3).
The generic quality of life in the patients with OMD
The SF-36 subscale scores did not show significant dif-
ference bewteen OMD and HS (p > 0.05), except in the
scores of Physical functioning (p = 0.001), Bodily pain
(p < 0.001) and General Health (p < 0.001) (Table 4).
The overall mean score of SF-36 was significantly lower
in the patients with OMD (74.54 ± 12.77) compared
with that in HS (77.97 ± 12.39). Age (p = 0.247, t-test)
and gender (p = 0.606, Chi-square test) did not affect
the SF-36 scores.
Furthermore, we compared the mean score of SF-36
in each group of OMD to HS. The mean score of SF-36
was significantly lower in the patients with RAS (72.66
± 11.68) (p = 0.001, t-test) and BMS & paraesthesia
(69.68 ± 12.64) (p < 0.001, t-test) compared with that in
HS. The mean scores of SF-36 did not show significant
difference bewteen the other 3 groups with OMD and
HS.
Discussion
The effects of illness on QoL can be related to the
impairment, disability and handicap [15]. In this study,
we evaluated of generic and oral QoL in overall OMDs
Table 1 Baseline characteristics of patients with OMD and HS
Age Gender
Years (range) p Male (%) p
Healthy Subjects n = 85 46.34 ± 16.69
(24-86)
31 (36.47%)
RAU (n = 163) 48.52 ± 16.21
(14-80)
0.322 76 (46.63%) 0.125
OLP (n = 121) 49.32 ± 16.18
(19-83)
0.200 33 (27.27%) 0.160
Oral Mucosal Disease BMS & Paraesthesia (n = 43) 51.93 ± 15.65
(20-79)
0.070 10 (23.23%) 0.130
Candidosis (n = 37) 49.62 ± 17.12
(20-78)
0.324 15 (40.54%) 0.670
Others (n = 174) 47.13 ± 17.64
(14-87)
0.731 78 (44.83%) 0.201
n = 538 48.60 ± 16.69
(14-87)
0.247 212 (39.41%) 0.606
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of OHIP-14 and SF-36 between OMD and HS. The
results yield additional information that may be relevant
and useful for the clinical management of patients with
OMD.
Our study is institutional based research. All patients
studied were recruited at the Department of Oral Muco-
sal Diseases, Shanghai Ninth People’s Hospital. Part of
the HS were recruited from a local community in
Shanghai, which was a relatively stable community. The
others were recruited from the family members of
patients with OMD studied. Some of the family mem-
bers of patients refused to participate the study. There-
fore the size of HS was lower than that of overall OMD
patients.
OMD are common, and many of them are unknown
cause. Patients with OMD can be suffered from life-threa-
tening symptom and be influenced daily life in many ways
which including a psycho-social effect as well as a func-
tional impact. Measurement of QoL may help to assess
unknown cause conditions. Mumcu et al. used OHIP-14
and SF-36 to measure the oral and general health related
QoL in the patients with Behçet’s disease, RAS and healthy
controls, and observed worseo r a lQ o Li nt h e s ep a t i e n t s
[10]. McGrath C et al. evaluated the sensitivity of two
patient-centred outcome measures to the topical applica-
tion of a corticosteroid (betamethasone) in the treatment
of OLP by UK Oral Health Related Quality Of Life mea-
sure (OHQOL-UK) and OHIP-14 [7]. Previous research
results also indicated that clinical oral disease such as
BMS and dry mouth could affect life quality using OHIP-
14, OHIP-49 and SF-36 [5,11]. Tabolli et al. used both spe-
cific and generic instruments including OHIP-14, SF-12,
and 12-item General Health Questionnaire questionaires
(GHQ-12) to study QoL affected by various oral mucosal
conditions [16]. They found that OMDs radically affected
QoL and were accompanied by a high frequency of psy-
chological problems. The similar result could be found in
the study by Llewellyn et al [17]. They used OHIP-14
questionaire and observed the greatest impairment to QoL
was register on physical pain. The measures employed in
this study were a oral health-related quality of life instru-
ment, the OHIP-14, and a generic health-related quality of
life instrument, the SF-36, which had been widely used
internationally. To the best of our knowledge, it is the first
time that both of OHIP-14 and SF-36 were used to evalu-
ate QoL in overall OMDs and control HS. We showed
that there was a significant lower scores in generic and
oral QoL for patients with OMD than that with HS. Our
study suggested that the evaluation of the effects of OMD
Table 2 The sum OHIP-14 in oral mucosal disease and healthy subjects.
Oral Mucosal Disease Healthy Subjects
Social Impact Item mean ± SD Median (IQR) mean ± SD Median (IQR) p
Functional limitation items 1.40 ± 1.82 1 (0-3) 0.95 ± 1.21 0 (0-2) 0.150
Trouble pronouncing 0.49 ± 0.98 0 (0-0) 0.44 ± 0.81 0 (0-1) 0.911
Taste worsened 0.91 ± 1.26 0 (0-2) 0.52 ± 0.72 0 (0-1) 0.113
Physical pain items 3.68 ± 2.43 4 (2-6) 1.76 ± 1.68 2 (0-3) < 0.001
Painful aching 1.92 ± 1.32 2 (1-3) 0.94 ± 0.94 1 (0-2) < 0.001
Uncomfortable to eat 1.76 ± 1.38 2 (0-3) 0.82 ± 0.92 1 (0-1.5) < 0.001
Psychological discomfort items 1.48 ± 1.87 1 (0-3) 0.67 ± 1.27 0 (0-1) < 0.001
Self-conscious 0.62 ± 1.05 0 (0-1) 0.34 ± 0.70 0 (0-0.5) 0.077
Tense 0.85 ± 1.11 0 (0-2) 0.33 ± 0.73 0 (0-0) < 0.001
Physical disability items 1.13 ± 1.66 0 (0-2) 0.76 ± 1.10 0 (0-1.5) 0.213
Diet unsatisfactory 0.60 ± 1.02 0 (0-1) 0.39 ± 0.66 0 (0-1) 0.319
Interrupt meals 0.53 ± 0.93 0 (0-1) 0.38 ± 0.67 0 (0-1) 0.396
Psychological disability items 1.28 ± 1.67 0 (0-2) 1.06 ± 1.42 0 (0-1) 0.393
Difficult to relax 0.81 ± 1.11 0 (0-2) 0.67 ± 0.89 0 (0-1) 0.516
Embarrassed 0.46 ± 0.84 0 (0-1) 0.39 ± 0.69 0 (0-1) 0.776
Social disability items 1.04 ± 1.45 0 (0-2) 0.74 ± 1.16 0 (0-1) 0.118
Irritable 0.73 ± 0.99 0 (0-1) 0.53 ± 0.78 0 (0-1) 0.137
Difficulty doing jobs 0.31 ± 0.71 0 (0-0) 0.21 ± 0.54 0 (0-0) 0.308
Handicap items 0.80 ± 1.39 0 (0-1) 0.60 ± 1.09 0 (0-1) 0.271
Life less satisfying 0.59 ± 0.96 0 (0-1) 0.44 ± 0.73 0 (0-1) 0.322
Unable to function 0.22 ± 0.62 0 (0-0) 0.16 ± 0.51 0 (0-0) 0.584
Total 10.81 ± 9.01 9 (4-15) 6.55 ± 6.73 4 (0.5-10) < 0.001
SD: standard deviation
IQR: interquartile range
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clinical decision processes.
Discriminant validity is the validity obtained when we
measure two things that are thought to be dissimilar
and our measures can discriminate between them. Allen
& Locker has previously discussed the discriminant
validity of OHIP [14]. They addressed that that the
OHIP could discriminate between clinically disparate
groups, while the SF-36 did not [18]. Hunt et al. sug-
gested that the SF-36 had an advantage over other simi-
lar instruments, such as the Nottingham health profile
[19]. Allen et al. reported that generic health can affect
a patient’s ability to tolerate dentures [18]. Our findings
indicated that the SF-36 score could discriminate
between overall OMDs and HS as well as sum OHIP-14
did. The probable reason for this was that many OMDs
were unknown cause and multisystem involved. How-
ever, we noticed that when OMDs categorizing into 5
groups, the mean score of sum OHIP-14 for RAS, OLP,
BMS & paraesthesia and others was significantly differ-
ent from HS. On the other hand, only RAS and BMS &
paraesthesia could be discriminated from HS by the
mean score of SF-36. The results of the study by Lopez-
Jornet P et al. showed that BMS yielded poorer quality
of life scores than the control group in all the domains
of the questionnaires including OHIP-49 and SF-36
[11]. This study could also show the same result
between BMS & paraesthesia and HS. It would be advi-
sable to use these in conjunction with classical instru-
ments for clinical diagnosis [20], meanwhile further
verification with large cohort is needed.
While this study showed an overall lower SF-36 score
for OMD patients, the result for the Physical Function-
ing sub-scale showed OMD were actually healthier on
this dimension. The probable reasons for this result
were: 1, OMDs were mainly confined in the oral cavity.
Therefore the influence by OMDs on Physical Function-
ing was limited. 2, With increased age the influence of
Physical Functioning could be influenced by systemic
disease. The mean age of the overall respondents was
over 45. A limitation of the study was that we did not
perform screening for systemic disease. Therefore, ‘HS’
only means participants without OMD, and does not
necessarily mean those without systemic disease.
In this study, the size of overall OMD and HS was not
homogeneous. We failed to collect more HS, because
some OMD patients’ family member rejected to be
involved. We also further grouped the observed OMDs
into 5 categories. However, we are aware that some
grouping may be arbitrary. The group named ‘others’
included very different OMDs and was created because
of small numbers (< 30).
Conclusions
Administration of specific and generic questionnaires of
QoL can provide a detailed picture of the impact of
OMDs on patients. Both oral and generic QoL were
impaired in the patients with OMD.
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